Clinicopathologic Assessment of Monoclonal Immunoglobulin-associated Renal Disease in the Kidney Allograft: A Retrospective Study and Review of the Literature
暂无分享,去创建一个
V. D’Agati | G. Appel | G. Markowitz | R. Crew | S. Kudose | I. Batal | P. Khairallah | Xiaoyi Ye | S. J. Swanson | Jeanne Kamal | D. C. Park
[1] G. Doros,et al. Long-term outcome of kidney transplantation in AL amyloidosis. , 2019, Kidney international.
[2] V. D’Agati,et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group , 2018, Nature Reviews Nephrology.
[3] V. D’Agati,et al. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases. , 2018, Journal of the American Society of Nephrology : JASN.
[4] F. Cosio,et al. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. , 2018, Kidney international.
[5] M. Stegall,et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] A. Israni,et al. OPTN/SRTR 2016 Annual Data Report: Kidney , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] B. Barlogie,et al. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease , 2017, American journal of hematology.
[8] H. Amer,et al. Recurrent Light Chain Proximal Tubulopathy in a Kidney Allograft. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] V. D’Agati,et al. Filgrastim-Induced Crescentic Transformation of Recurrent IgG2λ GN. , 2016, Journal of the American Society of Nephrology : JASN.
[10] M. Vankalakunti,et al. A case of primary renal allograft dysfunction due to myeloma cast nephropathy. , 2015, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[11] A. Dinda,et al. Monoclonal gammopathy of renal significance with light‐chain deposition disease diagnosed postrenal transplant: a diagnostic and therapeutic challenge , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[12] I. Étienne,et al. Light chain deposition disease and proximal tubulopathy in two successive kidney allografts. , 2014, Clinical nephrology.
[13] H. Rennke,et al. Anemia, fatigue, and late-failing kidney transplant. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] H. Rennke,et al. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in a kidney allograft. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] R. Minz,et al. Light chain deposition disease in a postrenal transplant patient , 2012, Indian journal of nephrology.
[16] J. Crowley,et al. Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma , 2012, Leukemia.
[17] K. Bellovich,et al. Myeloma cast nephropathy: a rare cause of primary renal allograft dysfunction. , 2011, Transplantation proceedings.
[18] Q. Qian,et al. De novo AL Amyloidosis in the Kidney Allograft , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] Q. He,et al. Unusual cause of proteinuria and re-renal failure after kidney transplantation: de novo localized AL amyloidosis in renal allograft , 2010, International Urology and Nephrology.
[20] F. Dekker,et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] V. Batuman,et al. Myeloma kidney with isolated tubulointerstitial light chain deposition in a renal allograft , 2009, Clinical transplantation.
[22] M. Picken,et al. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. , 2009, Archives of pathology & laboratory medicine.
[23] V. D’Agati,et al. Proliferative glomerulonephritis with monoclonal IgG deposits. , 2009, Journal of the American Society of Nephrology : JASN.
[24] F. Cosio,et al. Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. , 2009, Kidney international.
[25] H. Brenner,et al. Recent major improvement in long-term survival of younger patients with multiple myeloma. , 2008, Blood.
[26] Thomas M. Larsen,et al. Recurrence of light-chain deposition disease after renal transplantation , 2008, Scandinavian journal of urology and nephrology.
[27] A. Perkowska-Ptasinska,et al. Primary kidney allograft dysfunction due to myeloma-cast nephropathy: a case report. , 2007, Transplantation proceedings.
[28] E. Lerut,et al. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab? , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[29] D. Howell,et al. Lambda light chain deposition disease in a renal allograft. , 2005, Transplantation proceedings.
[30] V. D’Agati,et al. Primary renal allograft dysfunction. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] A. Fogo,et al. A middle-aged woman with refractory graft dysfunction in the early posttransplant period. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] C. Alpers,et al. De novo AL Amyloid in a Renal Allograft , 1998, American Journal of Nephrology.
[33] J. Myles,et al. De novo light-chain deposition disease in a cadaver renal allograft. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] Ross Ward,et al. United States Renal Data System , 2011 .
[35] W. Cook,et al. Bortezomib successfully reduces monoclonal serum free light chain levels in a patient with recurrent myeloma and cast nephropathy in the renal transplant. , 2009, Clinical transplants.
[36] M. Gertz,et al. Long-term outcome of renal transplantation in light-chain deposition disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.